What is the recommended dosage of ceftriaxone (Ceftriaxone) for the treatment of leptospirosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosage for Leptospirosis

The recommended dosage of ceftriaxone for treating leptospirosis is 1 gram intravenously once daily for 7 days. 1

Evidence-Based Rationale

Leptospirosis is a zoonotic disease caused by spirochetes of the genus Leptospira. The treatment approach depends on the severity of the disease:

For Severe Leptospirosis:

  • Dosage: 1 gram IV ceftriaxone once daily for 7 days 1
  • Alternative: 1.5 million units of IV penicillin G every 6 hours for 7 days 1

A prospective, randomized trial comparing these two regimens demonstrated equal efficacy in treating severe leptospirosis, with both medications showing a median time to fever resolution of 3 days and similar mortality rates (5 deaths in each treatment group) 1.

Benefits of Ceftriaxone:

  • Once-daily administration (vs. four times daily for penicillin G)
  • Extended spectrum of activity against other potential bacterial pathogens
  • Convenient dosing schedule improving compliance
  • Favorable safety profile compared to penicillin regimens 2

Emerging Evidence for Short-Course Treatment:

Some recent studies suggest that shorter courses of ceftriaxone (3-6 days) may be effective:

  • A retrospective study of 21 patients (including both uncomplicated and severe forms) showed that short-course ceftriaxone (1-2 g daily for less than 7 days) resulted in apyrexia within 2 days and no relapses 3
  • Another study reported favorable outcomes in 15 patients treated with ceftriaxone for less than 7 days 4

However, until larger clinical trials confirm these findings, the standard 7-day course remains the recommended approach.

Dosage Considerations

Dosage Adjustments:

  • Standard dose: 1 gram IV daily for 7 days
  • Higher dose option: 2 grams IV daily has been used in some studies with severe cases 2
  • No dosage adjustment is typically needed for renal impairment due to ceftriaxone's dual elimination pathway (both renal and hepatic)

Administration:

  • Can be administered intravenously or intramuscularly
  • IV administration is preferred for severe cases
  • Once-daily dosing is sufficient due to ceftriaxone's long half-life (5.8-8.7 hours) 5

Clinical Pearls

  • Begin antibiotic treatment as soon as leptospirosis is suspected, without waiting for laboratory confirmation
  • Monitor for clinical improvement, with fever typically resolving within 2-3 days of treatment initiation
  • Supportive care is essential, particularly for severe cases with organ dysfunction
  • Age above 50 years and infection with L. icterohaemorrhagiae serogroup are associated with more severe disease 4
  • Ceftriaxone offers practical advantages over penicillin G, including once-daily dosing and broader antimicrobial coverage

While short-course therapy shows promise, the standard 7-day treatment remains the established recommendation until larger studies confirm the efficacy of shorter regimens.

References

Research

Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003

Research

Use of ceftriaxone in patients with severe leptospirosis.

International journal of antimicrobial agents, 2006

Research

Short-course treatment with ceftriaxone for leptospirosis: a retrospective study in a single center in Eastern France.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.